• Info
  • Insider Ownership

Insider Trading & Ownership of Stephen Davis

Location
San Diego, CA
Summary
The estimated net worth of Stephen Davis is at least $4,300,156 dollars as of 20 Aug 2024. Stephen Davis is the CEO, Director of ACADIA PHARMACEUTICALS INC and owns shares of ACADIA PHARMACEUTICALS INC (ACAD) stock worth about $4.05M. Stephen Davis is the Director of HERON THERAPEUTICS, INC. /DE/ and owns shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) stock worth about $249.2K.
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Stephen Davis and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Stephen Davis has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $4,300,156.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ACADIA PHARMACEUTICALS INC ($4,050,942).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Stephen Davis

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACAD ACADIA PHARMACEUTICALS INC CEO, Director $4,050,942 16 Aug 2024
HRTX HERON THERAPEUTICS, INC. /DE/ Director $249,214 16 Dec 2022
BLCM BELLICUM PHARMACEUTICALS, INC Director 03 Jan 2023

Insider Transactions Reported by Stephen Davis:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored